Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 180

1.

Variable impairment of platelet functions in patients with severe, genetically linked immune deficiencies.

Nagy M, Mastenbroek TG, Mattheij NJA, de Witt S, Clemetson KJ, Kirschner J, Schulz AS, Vraetz T, Speckmann C, Braun A, Cosemans JMEM, Zieger B, Heemskerk JWM.

Haematologica. 2018 Mar;103(3):540-549. doi: 10.3324/haematol.2017.176974. Epub 2017 Dec 14.

2.

Macrovipecetin, a C-type lectin from Macrovipera lebetina venom, inhibits proliferation migration and invasion of SK-MEL-28 human melanoma cells and enhances their sensitivity to cisplatin.

Hammouda MB, Riahi-Chebbi I, Souid S, Othman H, Aloui Z, Srairi-Abid N, Karoui H, Gasmi A, Magnenat EM, Wells TNC, Clemetson KJ, Rodríguez-López JN, Essafi-Benkhadir K.

Biochim Biophys Acta Gen Subj. 2018 Mar;1862(3):600-614. doi: 10.1016/j.bbagen.2017.11.019. Epub 2017 Nov 28.

PMID:
29196192
3.

The Phosphatase Inhibitor Calyculin-A Impairs Clot Retraction, Platelet Activation, and Thrombin Generation.

Hudák R, Vincze J, Csernoch L, Beke Debreceni I, Oláh T, Erdődi F, Clemetson KJ, Kappelmayer J.

Biomed Res Int. 2017;2017:9795271. doi: 10.1155/2017/9795271. Epub 2017 Jun 7.

4.

The origins of major platelet receptor nomenclature.

Clemetson KJ.

Platelets. 2017 Jan;28(1):40-42. doi: 10.1080/09537104.2016.1204437. Epub 2016 Aug 11. Review.

PMID:
27715379
5.

Platelet receptors and patient responses: The contributions of Professor Stan Heptinstall to platelet research.

Clemetson KJ.

Platelets. 2015;26(5):382-5. doi: 10.3109/09537104.2015.1042449. Epub 2015 May 13.

PMID:
25970714
6.

Normal platelet activation profile in patients with peripheral arterial disease on aspirin.

van Geffen JP, Kleinegris MC, Verdoold R, Baaten CC, Cosemans JM, Clemetson KJ, Ten Cate H, Roest M, de Laat B, Heemskerk JW.

Thromb Res. 2015 Mar;135(3):513-20. doi: 10.1016/j.thromres.2014.12.029. Epub 2015 Jan 6.

PMID:
25600441
7.

Identification of platelet function defects by multi-parameter assessment of thrombus formation.

de Witt SM, Swieringa F, Cavill R, Lamers MM, van Kruchten R, Mastenbroek T, Baaten C, Coort S, Pugh N, Schulz A, Scharrer I, Jurk K, Zieger B, Clemetson KJ, Farndale RW, Heemskerk JW, Cosemans JM.

Nat Commun. 2014 Jul 16;5:4257. doi: 10.1038/ncomms5257.

8.

Echicetin coated polystyrene beads: a novel tool to investigate GPIb-specific platelet activation and aggregation.

Navdaev A, Subramanian H, Petunin A, Clemetson KJ, Gambaryan S, Walter U.

PLoS One. 2014 Apr 4;9(4):e93569. doi: 10.1371/journal.pone.0093569. eCollection 2014.

9.

Distinct effects of Re- and S-forms of LPS on modulating platelet activation.

Kappelmayer J, Beke Debreceni I, Vida A, Antal-Szalmás P, Clemetson KJ, Nagy B Jr.

J Thromb Haemost. 2013 Apr;11(4):775-8. doi: 10.1111/jth.12151. No abstract available.

10.

Potential therapeutic targeting of platelet-mediated cellular interactions in atherosclerosis and inflammation.

Nagy B Jr, Miszti-Blasius K, Kerenyi A, Clemetson KJ, Kappelmayer J.

Curr Med Chem. 2012;19(4):518-31. Review.

PMID:
22204330
11.

Platelets and primary haemostasis.

Clemetson KJ.

Thromb Res. 2012 Mar;129(3):220-4. doi: 10.1016/j.thromres.2011.11.036. Epub 2011 Dec 16. Review.

PMID:
22178577
12.

Angiotensin II-dependent hypertension causes reversible changes in the platelet proteome.

Gebhard S, Steil L, Peters B, Gesell-Salazar M, Hammer E, Kuttler B, Clemetson KJ, Scharf C, Peters J, Völker U, Rettig R, Greinacher A.

J Hypertens. 2011 Nov;29(11):2126-37. doi: 10.1097/HJH.0b013e32834b1991.

PMID:
21946693
13.

The role of platelets in defence against pathogens.

Clemetson KJ.

Hamostaseologie. 2011 Nov;31(4):264-8. doi: 10.5482/ha-1152. Epub 2011 Jun 28.

PMID:
21709931
14.

Snaclecs (snake C-type lectins) that inhibit or activate platelets by binding to receptors.

Clemetson KJ.

Toxicon. 2010 Dec 15;56(7):1236-46. doi: 10.1016/j.toxicon.2010.03.011. Epub 2010 Mar 27. Review.

PMID:
20350564
15.

Platelets and pathogens.

Clemetson KJ.

Cell Mol Life Sci. 2010 Feb;67(4):495-8. doi: 10.1007/s00018-009-0204-2. Epub 2009 Nov 21. Review. No abstract available.

PMID:
19936618
16.

Call for contributions to the new Methods section in Platelets.

Clemetson KJ, Harrison P, Heptinstall S.

Platelets. 2009 Nov;20(7):445. doi: 10.3109/09537100903313022. No abstract available.

PMID:
19845439
17.

Classification and nomenclature of snake venom C-type lectins and related proteins.

Clemetson KJ, Morita T, Kini RM.

Toxicon. 2009 Jul;54(1):83. doi: 10.1016/j.toxicon.2009.04.001. Epub 2009 Apr 9. No abstract available.

PMID:
19362105
18.

Scientific and standardization committee communications: classification and nomenclature of snake venom C-type lectins and related proteins.

Clemetson KJ, Morita T, Manjunatha Kini R; Registry of Exogenous Hemostatic Factors of SSC of the ISTH.

J Thromb Haemost. 2009 Feb;7(2):360. doi: 10.1111/j.1538-7836.2008.03233.x. Epub 2008 Nov 20. No abstract available.

19.

The crystal structure of the platelet activator aggretin reveals a novel (alphabeta)2 dimeric structure.

Hooley E, Papagrigoriou E, Navdaev A, Pandey AV, Clemetson JM, Clemetson KJ, Emsley J.

Biochemistry. 2008 Jul 29;47(30):7831-7. doi: 10.1021/bi800528t. Epub 2008 Jul 3.

PMID:
18597489
20.

Platelet GPIb complex as a target for anti-thrombotic drug development.

Clemetson KJ, Clemetson JM.

Thromb Haemost. 2008 Mar;99(3):473-9. doi: 10.1160/TH07-12-0718. Review.

PMID:
18327394
21.

L-amino acid oxidase from Naja atra venom activates and binds to human platelets.

Li R, Zhu S, Wu J, Wang W, Lu Q, Clemetson KJ.

Acta Biochim Biophys Sin (Shanghai). 2008 Jan;40(1):19-26.

22.

Snake venom proteins affecting platelets and their applications to anti-thrombotic research.

Clemetson KJ, Lu Q, Clemetson JM.

Curr Pharm Des. 2007;13(28):2887-92. Review.

PMID:
17979733
23.

Collagen receptors as potential targets for novel anti-platelet agents.

Clemetson KJ, Clemetson JM.

Curr Pharm Des. 2007;13(26):2673-83. Review.

PMID:
17897011
24.

A short history of platelet glycoprotein Ib complex.

Clemetson KJ.

Thromb Haemost. 2007 Jul;98(1):63-8. Review. No abstract available.

PMID:
17597992
25.

Profiling of alterations in platelet proteins during storage of platelet concentrates.

Thiele T, Steil L, Gebhard S, Scharf C, Hammer E, Brigulla M, Lubenow N, Clemetson KJ, Völker U, Greinacher A.

Transfusion. 2007 Jul;47(7):1221-33.

PMID:
17581157
26.
27.

Snake venom C-type lectins as tools in platelet research.

Clemetson KJ, Polgár J, Clemetson JM.

Platelets. 1998;9(3-4):165-9.

PMID:
16793696
28.

Snake C-type lectin-like proteins and platelet receptors.

Clemetson KJ, Lu Q, Clemetson JM.

Pathophysiol Haemost Thromb. 2005;34(4-5):150-5. Review.

29.

A common ancestral glycoprotein (GP) 9 1828A>G (Asn45Ser) gene mutation occurring in European families from Australia and Northern Europe with Bernard-Soulier Syndrome (BSS).

Liang HP, Morel-Kopp MC, Clemetson JM, Clemetson KJ, Kekomaki R, Kroll H, Michaelides K, Tuddenham EG, Vanhoorelbeke K, Ward CM.

Thromb Haemost. 2005 Sep;94(3):599-605.

PMID:
16268478
30.

Translocation of GPIb and Fc receptor gamma-chain to cytoskeleton in mucetin-activated platelets.

Lu Q, Clemetson JM, Clemetson KJ.

J Thromb Haemost. 2005 Sep;3(9):2065-76.

31.

Snake venoms and hemostasis.

Lu Q, Clemetson JM, Clemetson KJ.

J Thromb Haemost. 2005 Aug;3(8):1791-9. Review.

32.

Vascular biology--XIth International Meeting. 5-9 September 2000, Geneva, Switzerland.

Clemetson KJ.

IDrugs. 2000 Nov;3(11):1307-11. No abstract available.

PMID:
16047249
33.

The discovery and characterization of platelet GPIb.

Solum NO, Clemetson KJ.

J Thromb Haemost. 2005 Jun;3(6):1125-32. No abstract available.

34.

[Platelet inhibition and activation. Mechanisms and clinical implications].

Alberio L, Clemetson KJ.

Herz. 2005 May;30(3):176-80. Review. German.

35.

Snake venom C-type lectins interacting with platelet receptors. Structure-function relationships and effects on haemostasis.

Lu Q, Navdaev A, Clemetson JM, Clemetson KJ.

Toxicon. 2005 Jun 15;45(8):1089-98. Epub 2005 Apr 18. Review.

PMID:
15876445
36.

First isolation of actomyosin from a non-muscle cell: first isolated platelet protein.

Bettex-Galland M, Clemetson KJ.

J Thromb Haemost. 2005 May;3(5):834-9. No abstract available.

37.

All platelets are not equal: COAT platelets.

Alberio LJ, Clemetson KJ.

Curr Hematol Rep. 2004 Sep;3(5):338-43. Review.

PMID:
15341700
38.

Platelet activation induces metalloproteinase-dependent GP VI cleavage to down-regulate platelet reactivity to collagen.

Stephens G, Yan Y, Jandrot-Perrus M, Villeval JL, Clemetson KJ, Phillips DR.

Blood. 2005 Jan 1;105(1):186-91. Epub 2004 Aug 31.

PMID:
15339851
39.

Platelet receptor signalling.

Clemetson KJ, Clemetson JM.

Hematol J. 2004;5 Suppl 3:S159-63. Review. No abstract available.

PMID:
15190300
40.
41.
42.

High molecular weight kininogen regulates platelet-leukocyte interactions by bridging Mac-1 and glycoprotein Ib.

Chavakis T, Santoso S, Clemetson KJ, Sachs UJ, Isordia-Salas I, Pixley RA, Nawroth PP, Colman RW, Preissner KT.

J Biol Chem. 2003 Nov 14;278(46):45375-81. Epub 2003 Sep 2.

43.

Thrombospondin-1 mediates platelet adhesion at high shear via glycoprotein Ib (GPIb): an alternative/backup mechanism to von Willebrand factor.

Jurk K, Clemetson KJ, de Groot PG, Brodde MF, Steiner M, Savion N, Varon D, Sixma JJ, Van Aken H, Kehrel BE.

FASEB J. 2003 Aug;17(11):1490-2. Epub 2003 Jun 17.

PMID:
12824298
44.

Platelet receptors and their role in diseases.

Clemetson KJ.

Clin Chem Lab Med. 2003 Mar;41(3):253-60. Review.

PMID:
12705329
45.

Collagen response and glycoprotein VI function decline progressively as canine platelets age in vivo.

Alberio L, Friese P, Clemetson KJ, Dale GL.

Thromb Haemost. 2002 Sep;88(3):510-6.

PMID:
12353083
47.

Snake venom L-amino acid oxidases.

Du XY, Clemetson KJ.

Toxicon. 2002 Jun;40(6):659-65. Review. Erratum in: Toxicon 2002 Sep;40(9):1381.

PMID:
12175601
48.

Ophioluxin, a convulxin-like C-type lectin from Ophiophagus hannah (King cobra) is a powerful platelet activator via glycoprotein VI.

Du XY, Clemetson JM, Navdaev A, Magnenat EM, Wells TN, Clemetson KJ.

J Biol Chem. 2002 Sep 20;277(38):35124-32. Epub 2002 Jul 18.

49.

Crystal structure of the platelet glycoprotein Ib(alpha) N-terminal domain reveals an unmasking mechanism for receptor activation.

Uff S, Clemetson JM, Harrison T, Clemetson KJ, Emsley J.

J Biol Chem. 2002 Sep 20;277(38):35657-63. Epub 2002 Jun 26.

50.

Alboluxin, a snake C-type lectin from Trimeresurus albolabris venom is a potent platelet agonist acting via GPIb and GPVI.

Du Xiao-Yan, Magnenat E, Wells TN, Clemetson KJ.

Thromb Haemost. 2002 Apr;87(4):692-8.

PMID:
12008953

Supplemental Content

Loading ...
Support Center